The in vivo level of oxidative stress tends to increase with age in insects and mammals, as indicated by increasing exhalation of alkanes; this has been ascribed mainly to an increased rate of production of ROS rather than a decline in antioxidant defenses. There is additional supportive evidence for a link between aging and oxidative stress. The life span of Drosophila is extended by overexpression of human superoxide dismutase in motorneurons 4 and is shortened by exposure to high levels of oxygen. 5 Similarly, the life span of human diploid fibroblasts in vitro also is shortened by exposure to high levels of oxygen 6 and is extended by hypoxia. 7 Food restriction extends the life span of rats and is accompanied by a reduction in breath pentane excretion. 8 Oxidative stress has been implicated as a pathologic mechanism in aging and several diseases, but measuring its intensity in vivo has been difficult. 9 Various markers of oxidative stress have been proposed, including malonaldehyde and conjugated dienes in the blood and hydrocarbons and hydrogen peroxide in the breath. 10, 11 Volatile markers of oxidative stress have attracted attention because breath tests are intrinsically noninvasive and painless. 12 Increased breath alkanes, particularly ethane and pentane, have demonstrated increased oxidative stress in breast cancer, 13 rheumatoid arthritis, 14 heart transplant rejection, 15 acute myocardial infarction, 16 schizophrenia 17 and bronchial asthma. 18 Breath ethane and pentane are of limited value in screening for these disorders, because their sensitivity and specificity are poor.
However, oxidative stress appears to generate other degradation products that are excreted as VOCs in the breath. We have previously reported that the breath of normal human beings 19 and patients with lung cancer 20 contains longer-chain alkanes and that the concentrations of several of the C4 to C20 alkanes increases with age. 21 We report here the results of examining another molecular dimension-the alkane methylation site-to produce a three-dimensional graph, the BMAC, and its variation with age.
METHODS
Collection of breath and air samples. VOCs in breath and room air were collected with a breath collection apparatus, a portable microprocessor-controlled device. Each subject wore a nose clip while inspiring and expiring through a low-resistance disposable mouthpiece into a wide-bore breath reservoir (1.0-inch diameter) open to the atmosphere at its distal end. The breath reservoir was heated to prevent condensation. Alveolar breath was pumped from the breath reser- . The geometry of the system ensured that the sample comprised alveolar breath virtually uncontaminated by dead-space air. Two separate samples were collected: alveolar breath and background room air, each containing VOCs in 1.0 L collected over 2.0 minutes at 0.5 L/min. The collection method has been described in greater detail elsewhere. 19, 22 Breath VOC assay. VOCs were desorbed from the sorbent trap by heating it to 300°C in an automated thermal desorber (ATD 400; Perkin Elmer, Norwalk, CT). A stream of helium flushed the VOCs onto a concentrator, a refrigerated sorbent trap maintained at 0°C. The concentrated sample of VOCs was then heated to 300°C, and the volatilized VOCs were separated by gas chromatography and identified and quantified by mass spectroscopy. The assay method has been described in greater detail elsewhere. 19, 22 Human subjects. Breath samples were collected between 7.00 AM and noon from 102 normal volunteers between 9 and 89 years of age who had fasted from the previous midnight. Subjects sat for approximately 20 minutes before the collections of breath and air to allow time for equilibration between VOCs in room air and in the blood. The institutional review board of the Sisters of Charity Medical Center, St Vincent's Campus, Staten Island, NY, approved the human research.
Analysis of data. The RA of each alkane (C4 to C20) and its monomethylated derivatives were determined from the chromatographic AUC and the AUC of an internal standard (0.25 mL of 2 ppm 1-bromo-4-fluorobenzene; Supelco) (RA VOC = AUC VOC /AUC internal standard ). The alveolar gradient of each VOC was determined as RA breath -RA room air . 19 In each subject, a BMAC was constructed by plotting alkane carbon skeleton length (x-axis) versus methylation site (zaxis) versus alveolar gradient (y-axis).
RESULTS
Seventy-three different C4 to C20 alkanes and monomethylated alkanes were observed at least once in the breath samples. Subjects, in groups of 25 or 26, were assigned to four quartiles according to their age, ranging from the first quartile (the youngest quarter of the population) to the fourth quartile (the oldest quarter of the population). Breath data were pooled from subjects in each quartile to determine their mean alveolar gradients of alkanes and monomethylated alkanes. These values were displayed as the BMAC for each quartile (Fig 2) ; significant differences between quartiles were determined with one-way analysis of variance and a Newman-Keuls post hoc test (Table I ). The combined mean alveolar gradient of all alkanes and monomethylated alkanes in each quartile are shown in Fig 3; these exhibited highly significant increases in the third and fourth quartiles as compared with the first. When subjects were matched for age, the only difference with sex was 4-methyloctane (greater in females than in males, P < .05, two-tailed t test); there was an insufficient number of tobacco smokers in the study group for a meaningful statistical comparison with nonsmokers.
DISCUSSION
Our study demonstrated three main findings: (1) normal human breath contains a greater number of alkanes and monomethylated alkanes than previously reported; (2) the alveolar gradients of several of these VOCs were significantly more positive in older than in younger normal human beings; (3) the combined mean alveolar gradient of all VOCs in the BMAC significantly increased with age, from negative in the youngest to positive in the oldest.
To interpret these findings, two separate issues need to be considered: (1) the qualitative significance of alkanes and monomethylated alkanes in the breath, and (2) the quantitative significance of their alveolar gradients.
Alkanes in the breath are qualitatively significant as markers of oxidative stress. This has been extensively documented in other reports, most of which have focused on ethane and pentane. However, Kneepkens Pentane, 2-methyl - et al have shown that oxidative stress elicits the production of other alkanes besides ethane and pentane. In summary, ROS peroxidate a PUFA with n carbons to lipid alkoxyl radical, which is then converted by beta scission to an alkane with n-1 carbons. PUFAs composed of three and six carbons are converted to ethane and pentane, respectively, but the same mechanism generates other alkanes including propane, butane, hexane, heptane, and octane. 10, 11 Consequently, all of the C4 to C20 alkanes observed in this study appear to be markers of oxidative stress. Methylated alkanes have not been studied in comparable detail, and further research is required to document their biosynthetic pathways. However, our findings suggest that methylated alkanes are also markers of oxidative stress, and this hypothesis could be tested experimentally because it predicts that these VOCs would be manufactured in cells, tissues, or intact animals subjected to pharmacologic oxidative stress. The quantitative significance of the BMAC is determined by the physiologic basis of the alveolar gradient. We have previously analyzed the kinetics of breath VOCs and demonstrated the following relationship 19 :
where R = rate of movement of VOC (mol/min) and RMV = respiratory minute volume (L/min). This equation demonstrates that the age-related increase in the alveolar gradients of alkanes and methylated alkanes may have been caused by an increase in their rate of . This value varied from negative in the first, second, and third quartiles to positive in the fourth quartile, and the changes were highly significant with advancing age in subjects over 40 years of age. This demonstrates that the overall elevation in components of the BMAC with age, which is visually apparent in Fig 2, is statistically significant as well. The probable pathophysiologic basis of these changes was an age-related increase in oxidative stress causing increased synthesis of alkanes and methylated alkanes, although an age-related decline in cytochrome p450 clearance of these compounds may have contributed to the effect.
synthesis, a decrease in their rate of clearance, or both. There is evidence for both processes, and it is not apparent which is quantitatively the most important. Previous studies have shown that breath pentane increases with age in healthy normal human beings. 23, 24 Sagai and Ichinose 25 demonstrated age-related increases in lipid peroxidation in rats, as shown by increased excretion of ethane, butane, and pentane in breath, and Sohal et al 26 observed increased exhalation of pentane with age in the male housefly, Musca domestica. In all of these studies, the findings were ascribed to an age-related increase in oxidative stress resulting in a commensurate increase in the rate of synthesis of alkanes. However, these changes might also have been influenced by a reduced rate of clearance resulting from the age-related decline in hepatic cytochrome p450 activity that is known to cause a commensurate decline in the clearance of some drugs. 27, 28 Whether this process significantly affects alkanes and methylated alkanes in the breath is unclear, because not all hydroxylation enzymes are similarly affected; for example, there is no age-related decline in the activity of cutaneous aryl hydrocarbon hydroxylase 29 nor of the hepatic microsomal hydroxylation of alprazolam. 30 It will be noted in Figs 2 and 3 that we used the relative abundance of VOCs rather than their absolute concentrations in mass or molar units. The combination of gas chromatography with mass spectroscopy and an internal standard yields a value for the RA of a VOC:
where AUC = area under the curve of chromatographic peak.
The RA value can then be converted into the absolute concentration of the VOC in mass or molar units by reference to a standard curve for that VOC. However, this requires that an individual standard curve must be constructed for every VOC observed. We have previously reported these standard curves for C4 to C20 alkanes but not for methylalkanes. Construction of standard curves for approximately 80 different methylalkanes was not undertaken in this study for two main reasons: (1) the task would be extremely laborious, time-consuming, and technically challenging; (2) it would add very little to the results or the interpretation of the data. Because the relationship between the RA and the molar concentration of a VOC is linear, the appearance of the BMAC would be little changed and the results of statistical analysis of data would not be changed at all.
The main limitation of this study is that it did not demonstrate a direct causal linkage between oxidative stress and the components of the BMAC. This linkage was inferred from two previously documented observations: (1) aging causes increased oxidative stress, and (2) increased oxidative stress causes increased excretion of alkanes in the breath. Because this was a pilot study of normal human beings ranging from children to the elderly, it was not feasible to test this hypothesis by introducing any additional stressor that might elicit oxidative stress. However, we are actively pursuing studies in human subjects, in animals, and in cell cultures to evaluate the effects of disease and induced oxidative stress on the production of alkanes and methylated alkanes.
We conclude that the alveolar gradients of several C4 to C20 alkanes and monomethylated alkanes in the breath increased significantly with age in normal human beings, and the BMAC may provide a clinically useful display of these apparent new markers of oxidative stress. However, further research is needed to confirm this proposed causal linkage between oxidative stress and the BMAC. With this caveat in mind, the breath test may have several potential applications, particularly in diagnostic screening for diseases that are associated with increased oxidative stress. We are currently evaluating the BMAC in multi-center clinical studies of a number of conditions including lung cancer, breast cancer, and heart transplant rejection. The BMAC also has potential applications in other areas of research including the study of aging, in toxicology for estimating the effects of pro-oxidant toxins, and in pharmacology for evaluating the effects of antioxidants.
